Paris – Antimicrobial resistant bacteria not only put their lives at risk, but also focus on health systems: they can raise annual expenditure to $ 3.5 billion per 2050 in each OECD country. According to a report published on Wednesday.
"These bacteria are more expensive than flu from tuberculosis AIDS. And it would be even more expensive if states did not act to solve this problem.Michele Cechini, a public health expert at the OECD (Organization for Economic Co-operation and Development), told AFP.
According to him, countries are already devoting an average of 10% of their health budgets to the treatment of bacteria resistant to antibiotics.
According to projections in 33 reports of 36 OECD countries, resistant bacteria can kill 2.4 million people in Europe, North America and Australia in 2050.
A separate study published in The Lancet Journal of Infectious Diseases on Monday estimates that in 2015 there were 33,000 deaths from these bacteria in the European Union.
Still, we could fight them.simple measures; At a moderate cost compared to OECD:Promotes better hygiene"(eg, by washing your hands with encouragement)"Excessive antibiotic prescription"or generalize rapid diagnostic tests to determine whether an infection is viral (in which case antibiotics are useless) or bacterial.
According to the OECD, these measures will cost 2 US dollars per person per year and will prevent three-quarters of deaths.
"Investments in a large public health program, including some of these measures, can be redeemed within a year and result in savings of $ 4.8 billion per year."Judges the OECD.
Health authorities, which begin with the World Health Organization (WHO), regularly warn against the danger of excessive resistance to antibiotics, and this leads to the proliferation of resistant bacteria. Young children and the elderly are particularly at risk.
"In Brazil, Indonesia and Russia, 40% to 60% of infections are already resistant to an average of 17% in OECD countries."emphasizes the latter.
More worrying, "Resistance to second or third order antibiotics is expected to be 70% higher than 2030 in 2005However, these antibiotics should be used as a last resort when no other solution is available.